量研学術機関リポジトリ「QST-Repository」は、国立研究開発法人 量子科学技術研究開発機構に所属する職員等が生み出した学術成果（学会誌発表論文、学会発表、研究開発報告書、特許等）を集積しインターネット上で広く公開するサービスです。 Welcome to QST-Repository where we accumulates and discloses the academic research results(Journal Publications, Conference presentation, Research and Development Report, Patent, etc.) of the members of National Institutes for Quantum Science and Technology.
Thank you very much for using our website. On the 11th of March 2019, this site was moved from our own network server to the JAIRO Cloud network server. If you previously bookmarked this site, that bookmark will no longer work. We would be grateful if you could bookmark the website again. Thank you very much for your understanding and cooperation.
Reduced Sympathetic Nervous Function is Useful Marker to Detect Cardiac Sarcoidosis among Patients with Extracardiac Sarcoidosis and Suspected Cardiac Involvement using C-11 Hydroxyephedrine PET/CT
利用統計を見る
Background: The cardiac involvement is a major cause of mortality in patients with sarcoidosis. Diagnostic criteria of cardiac sarcoidosis (CS) have been proposed. However, the diagnosis of CS is still challenge. The clinical manifestation of CS is mainly associated with arrhythmia and heart failure. Cardiac sympathetic nervous system (SNS) dysfunction may have an important pathophysiological role for heart failure and arrhythmia in CS. Thus, underling SNS dysfunction may have a role for detecting CS. However, this possibility has not been studied. The purpose of this study was to evaluate whether SNS dysfunction was able to detect cardiac involvement using C-11 hydroxyephedrine (HED) PET/CT in patients with suspected CS.
Methods: Nineteen patients with biopsy proven extracardiac sarcoidosis were undergone fasting F-18 FDG and C-11 HED PET/CT. Left ventricular (LV) wall was divided into 17 segments. Regional focal FDG uptake was defined as positive. Whole LV HED uptake was quantitatively assessed using retention index (RI). CS was diagnosed by the Japanese Ministry of Health, Labor, and Welfare guidelines.
Results: CS patients (n=13, age 60±15 y) and non CS (n=6, age 67±10 y) sarcoidosis patients had similar LVEF (61.2±15.7 vs. 68.8±8.7%, P=0.26). CS showed higher frequency of focal FDG uptake compared to non CS (53% vs. 0%, P=0.024). CS showed reduced global LV HED RI compared to non CS (0.08±0.04 vs 0.16±0.03 %/min, P=0.001). Using cut off value of HED RI as 0.064/min based on receiver operating analysis, the sensitivity for detecting CS was 76% and specificity was 100%. The area under curve was 0.92.
Conclusions: CS showed global LV SNS dysfunction even though their LVEF was similar to non CS. Reduced SNS function was sensitive and highly specific for detecting CS. In contrast, 47% of CS did not have FDG positive. Thus, global SNS reduction may be a useful diagnostic marker of CS.
会議概要（会議名, 開催地, 会期, 主催者等）
62nd Society of Nuclear Medicine and Molecular Imaging
Reduced Sympathetic Nervous Function is Useful Marker to Detect Cardiac Sarcoidosis among Patients with Extracardiac Sarcoidosis and Suspected Cardiac Involvement using C-11 Hydroxyephedrine PET/CT
